← FDA DRUG APPROVALS

FDA ANDA · ANDA075750

DOXAZOSIN MESYLATE

Sponsor: PLIVA

APPLICATION
ANDA075750
TYPE
ANDA
ORIGINAL APPROVAL
2001-06-08
LATEST ACTION
2002-08-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 8MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 2MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 4MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 1MG BASE · TABLET · ORAL

Approval history

2002-08-02Labeling · Supplement 2AP
2001-06-08Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →